CACH syndrome
Synonyms: Childhood ataxia with diffuse central nervous system hypomyelination · Leukoencephalopathy with vanishing white matter · Myelinosis centralis diffusa
- Type
- Disease
- Group
- Disorder
- Inheritance
- Autosomal recessive
- Age of onset
- Childhood
- Status
- active
A new leukoencephalopathy, the CACH syndrome (Childhood Ataxia with Central nervous system Hypomyelination) or VWM (Vanishing White Matter) was identified on clinical and MRI criteria. Classically, this disease is characterized by (1) an onset between 2 and 5 years of age, with a cerebello-spastic syndrome exacerbated by episodes of fever or head trauma leading to death after 5 to 10 years of disease evolution, (2) a diffuse involvement of the white matter on cerebral MRI with a CSF-like signal intensity (cavitation), (3) a recessive autosomal mode of inheritance, (4) neuropathologic findings consistent with a cavitating orthochromatic leukodystrophy with increased number of oligodendrocytes with sometimes ``foamy'' aspect.
Names in Orphadata languages
12 of 12 languages| Lang | Name | Synonyms |
|---|---|---|
| en | CACH syndrome | Childhood ataxia with diffuse central nervous system hypomyelination · Leukoencephalopathy with vanishing white matter · Myelinosis centralis diffusa |
| fr | Syndrome CACH | Ataxie infantile avec hypomyélinisation diffuse du système nerveux central · Leucoencéphalopathie avec perte de substance blanche · Myélinolyse centrale diffuse |
| de | CACH-Syndrom | Infantile Ataxie mit diffuser Hypomyelinisierung des ZNS · Leukoenzephalopathie mit Verlust der weissen Hirnsubstanz · Myelinosis centralis diffusa |
| es | Síndrome CACH | Ataxia infantil con hipomielinización del sistema nervioso central · Leucoencefalopatía con desaparición de la sustancia blanca · Mielinosis central difusa |
| it | Sindrome CACH | Atassia infantile con ipomielinizzazione diffusa del sistema nervoso centrale · Leucoencefalopatia con perdita della sostanza bianca · Mielinolisi centrale diffusa |
| nl | CACH-syndroom | Ataxie op kinderleeftijd met diffuse hypomyelinisatie van centraal zenuwstelsel · Leuko-encefalopathie met verdwijnende witte stof · Myelinosis centralis diffusa |
| pt | Síndrome CACH | Ataxia infantil com hipomielinização difusa do SNC · Leucoencefalopatia com desaparecimento de substância branca · Mielinose central difusa |
| pl | Zespół CACH | Dziecięca ataksja z rozlaną hipomielinizacją centralnego układu nerwowego · Leukoencefalopatia z zanikającą istotą białą · Myelinosis centralis diffusa |
| cs | CACH syndrom | Leukoencefalopatie s mizející bílou hmotou · Myelinosis centralis diffusa · Dětská ataxie s difuzní hypomyelinizací centrálního nervového systému |
| uk | CACH-синдром | Дитяча атаксія з дифузною гіпомієлінізацією центральної нервової системи · Лейкоенцефалопатія зі зникненням білої речовини · Центральний дифузний мієліноз |
| zh | CACH综合征 | 弥漫性中枢神经系统髓鞘形成减少伴儿童期共济失调 |
| tr | CACH sendromu | Myelinozis sentralis diffusa · Kaybolan beyaz cevher ile seyreden lökoensefalopati · Yaygın merkezi sinir sistemi hipomiyelinizasyon ile seyreden çocukluk çağı ataksisi |
Definition in:
Cross-references
qualifier = Orphanet mapping relation| Source | Code | Qualifier | ICD relation | Validation |
|---|---|---|---|---|
| OMIM | 603896 | E | validated | |
| OMIM | 615889 | BTNT | validated | |
| OMIM | 620312 | BTNT | validated | |
| OMIM | 620313 | BTNT | validated | |
| OMIM | 620314 | BTNT | validated | |
| OMIM | 620315 | BTNT | validated | |
| ICD-10 | E75.2 | NTBT | attributed | validated |
| ICD-11 | 8A44.3 | NTBT | index | validated |
| MONDO | 0800448 | E | validated | |
| UMLS | C1858991 | E | validated | |
| GARD | 231 | E | validated |
E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.
Classification
Preferential parent (Orphanet linearisation):
Parents in the classifications (1):
- ORPHA:68356Leukodystrophy
rare genetic diseases; rare neurological diseases
Genes
0 direct · 26 via subtypesOrphanet records no gene directly on this code.
Recorded by Orphanet on subtypes of this disorder:
| Gene | Subtype | Association | Status | HGNC | Ensembl | OMIM | Locus | Name | Source of validation |
|---|---|---|---|---|---|---|---|---|---|
| AARS2 | ORPHA:99853Ovarioleukodystrophy | Disease-causing germline mutation(s) (loss of function) in | Assessed | HGNC:21022 | ENSG00000124608 | 612035 | 6p21.1 | alanyl-tRNA synthetase 2, mitochondrial | 24808023[PMID] |
| EIF2B1 | ORPHA:99853Ovarioleukodystrophy | Disease-causing germline mutation(s) in | Assessed | HGNC:3257 | ENSG00000111361 | 606686 | 12q24.31 | eukaryotic translation initiation factor 2B subunit alpha | 20301435[PMID]_15136673[PMID] |
| EIF2B1 | ORPHA:99854Cree leukoencephalopathy | Disease-causing germline mutation(s) in | Assessed | HGNC:3257 | ENSG00000111361 | 606686 | 12q24.31 | eukaryotic translation initiation factor 2B subunit alpha | 20301435[PMID]_15136673[PMID] |
| EIF2B1 | ORPHA:157713Congenital or early infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3257 | ENSG00000111361 | 606686 | 12q24.31 | eukaryotic translation initiation factor 2B subunit alpha | 20301435[PMID] |
| EIF2B1 | ORPHA:157716Late infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3257 | ENSG00000111361 | 606686 | 12q24.31 | eukaryotic translation initiation factor 2B subunit alpha | 20301435[PMID] |
| EIF2B1 | ORPHA:157719Juvenile or adult CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3257 | ENSG00000111361 | 606686 | 12q24.31 | eukaryotic translation initiation factor 2B subunit alpha | 20301435[PMID] |
| EIF2B2 | ORPHA:99853Ovarioleukodystrophy | Disease-causing germline mutation(s) in | Assessed | HGNC:3258 | ENSG00000119718 | 606454 | 14q24.3 | eukaryotic translation initiation factor 2B subunit beta | 20301435[PMID]_15136673[PMID] |
| EIF2B2 | ORPHA:99854Cree leukoencephalopathy | Disease-causing germline mutation(s) in | Assessed | HGNC:3258 | ENSG00000119718 | 606454 | 14q24.3 | eukaryotic translation initiation factor 2B subunit beta | 20301435[PMID]_15136673[PMID] |
| EIF2B2 | ORPHA:157713Congenital or early infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3258 | ENSG00000119718 | 606454 | 14q24.3 | eukaryotic translation initiation factor 2B subunit beta | 20301435[PMID] |
| EIF2B2 | ORPHA:157716Late infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3258 | ENSG00000119718 | 606454 | 14q24.3 | eukaryotic translation initiation factor 2B subunit beta | 20301435[PMID] |
| EIF2B2 | ORPHA:157719Juvenile or adult CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3258 | ENSG00000119718 | 606454 | 14q24.3 | eukaryotic translation initiation factor 2B subunit beta | 20301435[PMID] |
| EIF2B3 | ORPHA:99853Ovarioleukodystrophy | Disease-causing germline mutation(s) in | Assessed | HGNC:3259 | ENSG00000070785 | 606273 | 1p34.1 | eukaryotic translation initiation factor 2B subunit gamma | 20301435[PMID]_15136673[PMID] |
| EIF2B3 | ORPHA:99854Cree leukoencephalopathy | Disease-causing germline mutation(s) in | Assessed | HGNC:3259 | ENSG00000070785 | 606273 | 1p34.1 | eukaryotic translation initiation factor 2B subunit gamma | 20301435[PMID]_15136673[PMID] |
| EIF2B3 | ORPHA:157713Congenital or early infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3259 | ENSG00000070785 | 606273 | 1p34.1 | eukaryotic translation initiation factor 2B subunit gamma | 20301435[PMID] |
| EIF2B3 | ORPHA:157716Late infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3259 | ENSG00000070785 | 606273 | 1p34.1 | eukaryotic translation initiation factor 2B subunit gamma | 20301435[PMID] |
| EIF2B3 | ORPHA:157719Juvenile or adult CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3259 | ENSG00000070785 | 606273 | 1p34.1 | eukaryotic translation initiation factor 2B subunit gamma | 20301435[PMID] |
| EIF2B4 | ORPHA:99853Ovarioleukodystrophy | Disease-causing germline mutation(s) in | Assessed | HGNC:3260 | ENSG00000115211 | 606687 | 2p23.3 | eukaryotic translation initiation factor 2B subunit delta | 20301435[PMID]_15136673[PMID] |
| EIF2B4 | ORPHA:99854Cree leukoencephalopathy | Disease-causing germline mutation(s) in | Assessed | HGNC:3260 | ENSG00000115211 | 606687 | 2p23.3 | eukaryotic translation initiation factor 2B subunit delta | 20301435[PMID]_15136673[PMID] |
| EIF2B4 | ORPHA:157713Congenital or early infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3260 | ENSG00000115211 | 606687 | 2p23.3 | eukaryotic translation initiation factor 2B subunit delta | 20301435[PMID] |
| EIF2B4 | ORPHA:157716Late infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3260 | ENSG00000115211 | 606687 | 2p23.3 | eukaryotic translation initiation factor 2B subunit delta | 20301435[PMID] |
| EIF2B4 | ORPHA:157719Juvenile or adult CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3260 | ENSG00000115211 | 606687 | 2p23.3 | eukaryotic translation initiation factor 2B subunit delta | 20301435[PMID] |
| EIF2B5 | ORPHA:99853Ovarioleukodystrophy | Disease-causing germline mutation(s) in | Assessed | HGNC:3261 | ENSG00000145191 | 603945 | 3q27.1 | eukaryotic translation initiation factor 2B subunit epsilon | 20301435[PMID]_15136673[PMID] |
| EIF2B5 | ORPHA:99854Cree leukoencephalopathy | Disease-causing germline mutation(s) in | Assessed | HGNC:3261 | ENSG00000145191 | 603945 | 3q27.1 | eukaryotic translation initiation factor 2B subunit epsilon | 20301435[PMID]_15136673[PMID] |
| EIF2B5 | ORPHA:157713Congenital or early infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3261 | ENSG00000145191 | 603945 | 3q27.1 | eukaryotic translation initiation factor 2B subunit epsilon | 20301435[PMID] |
| EIF2B5 | ORPHA:157716Late infantile CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3261 | ENSG00000145191 | 603945 | 3q27.1 | eukaryotic translation initiation factor 2B subunit epsilon | 20301435[PMID] |
| EIF2B5 | ORPHA:157719Juvenile or adult CACH syndrome | Disease-causing germline mutation(s) in | Assessed | HGNC:3261 | ENSG00000145191 | 603945 | 3q27.1 | eukaryotic translation initiation factor 2B subunit epsilon | 20301435[PMID] |
Prevalence and incidence
2 records| Type | Class | Value | Area | Qualification | Validation | Source |
|---|---|---|---|---|---|---|
| Cases/families | 148 cases | Worldwide | Case(s) | Validated | ORPHANET | |
| Point prevalence | Unknown | — | Worldwide | Class only | Validated | ORPHANET |
Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.
HPO phenotypes
55 annotations · validated 2020-12-18| HPO | Term (as annotated by Orphanet) | Diagnostic |
|---|---|---|
| Very frequent (99-80%) | ||
| HP:0410263 | Brain imaging abnormality | |
| HP:0006978 | Dysmyelinating leukodystrophy | |
| Frequent (79-30%) | ||
| HP:0007366 | Atrophy/Degeneration affecting the brainstem | |
| HP:0001272 | Cerebellar atrophy | |
| HP:0006855 | Cerebellar vermis atrophy | |
| HP:0002059 | Cerebral atrophy | |
| HP:0001347 | Hyperreflexia | |
| HP:0000737 | Irritability | |
| HP:0002070 | Limb ataxia | |
| HP:0000648 | Optic atrophy | |
| HP:0008209 | Premature ovarian insufficiency | |
| HP:0002344 | Progressive neurologic deterioration | |
| HP:0001250 | Seizure | |
| HP:0001257 | Spasticity | |
| HP:0002078 | Truncal ataxia | |
| Occasional (29-5%) | ||
| HP:0007361 | Abnormality of the pons | |
| HP:0000741 | Apathy | |
| HP:0002804 | Arthrogryposis multiplex congenita | |
| HP:0000708 | Atypical behavior | |
| HP:0000618 | Blindness | |
| HP:0000518 | Cataract | |
| HP:0100543 | Cognitive impairment | |
| HP:0001558 | Decreased fetal movement | |
| HP:0001260 | Dysarthria | |
| HP:0032398 | Dysgyria | |
| HP:0001310 | Dysmetria | |
| HP:0002015 | Dysphagia | |
| HP:0001298 | Encephalopathy | |
| HP:0011968 | Feeding difficulties | |
| HP:0001371 | Flexion contracture | |
| HP:0008947 | Floppy infant | |
| HP:0033049 | Globus pallidus hypointensity on susceptibility-weighted imaging | |
| HP:0000133 | Gonadal dysgenesis | |
| HP:0001510 | Growth delay | |
| HP:0002315 | Headache | |
| HP:0001269 | Hemiparesis | |
| HP:0001433 | Hepatosplenomegaly | |
| HP:0001511 | Intrauterine growth retardation | |
| HP:0006956 | Lateral ventricle dilatation | |
| HP:0000252 | Microcephaly | |
| HP:0002076 | Migraine | |
| HP:0011342 | Mild global developmental delay | |
| HP:0001270 | Motor delay | |
| HP:0008288 | Nonketotic hyperglycinemia | |
| HP:0001562 | Oligohydramnios | |
| HP:0100653 | Optic neuritis | |
| HP:0001733 | Pancreatitis | |
| HP:0000786 | Primary amenorrhea | |
| HP:0000089 | Renal hypoplasia | |
| HP:0000869 | Secondary amenorrhea | |
| HP:0001264 | Spastic diplegia | |
| HP:0012690 | T2 hypointense thalamus | |
| HP:0002013 | Vomiting | |
| HP:0012704 | Widened subarachnoid space | |
| Very rare (<4-1%) | ||
| HP:0004481 | Progressive macrocephaly | |
Run the differential on the 2 obligate / very frequent terms
Annotation source: 29740943[PMID]_20301435[PMID]
Sources for this card
- Orphanet page: orpha.net/en/disease/detail/135
- This record as JSON: /data/d/135.json